Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patients
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 24, Issue 11, Pages 2813-2818
Publisher
Oxford University Press (OUP)
Online
2013-10-12
DOI
10.1093/annonc/mdt370
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors
- (2012) Jinjia Chang et al. BREAST CANCER RESEARCH AND TREATMENT
- Peripheral Blood Immune Cell Methylation Profiles Are Associated with Nonhematopoietic Cancers
- (2012) D. C. Koestler et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Is There a Link Between Genome-Wide Hypomethylation in Blood and Cancer Risk?
- (2012) K. Brennan et al. Cancer Prevention Research
- Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk
- (2012) K. Brennan et al. CANCER RESEARCH
- Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking
- (2012) Natalie S. Shenker et al. HUMAN MOLECULAR GENETICS
- Quantitative DNA Methylation Analysis Identifies a Single CpG Dinucleotide Important for ZAP-70 Expression and Predictive of Prognosis in Chronic Lymphocytic Leukemia
- (2012) Rainer Claus et al. JOURNAL OF CLINICAL ONCOLOGY
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research
- (2011) N Shenker et al. BRITISH JOURNAL OF CANCER
- Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival
- (2011) W. Dai et al. CLINICAL CANCER RESEARCH
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
- (2010) MP Coleman et al. LANCET
- Common variants at 19p13 are associated with susceptibility to ovarian cancer
- (2010) Kelly L Bolton et al. NATURE GENETICS
- Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies
- (2009) Claudio Zamagni et al. ENDOCRINE-RELATED CANCER
- Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients
- (2009) James M. Flanagan et al. HUMAN MOLECULAR GENETICS
- Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients
- (2009) Barbara Banelli et al. INTERNATIONAL JOURNAL OF CANCER
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started